Eric M Dube sold $3.6M of Travere Therapeutics (TVTX)

Executed Oct 28 2025, disclosed Oct 30 2025, 2 days later.

Value, as filed

$3.6M

120,000 sh across 2 lots

Executed

Oct 28 2025

the trade date, as filed

Disclosed

Oct 30 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Eric M Dube CHIEF EXECUTIVE OFFICER profile →

Eric M Dube (CHIEF EXECUTIVE OFFICER) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $25.4M of TVTX (399,730 sh across 7 lots, as filed), executed Sep 15.

The name

TVTX

Travere Therapeutics, Inc. TVTX · Healthcare · 74 filings in 24 months ticker →

Healthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eric M Dube in TVTX

TVTXSALE Travere Therapeutics, Inc. $25.4M
399,730 sh across 7 lots
Exec Sep 15
Filed Sep 17 · 9:31 PM ET TVTXSALE Travere Therapeutics, Inc. $989K
22,500 sh × $43.95
Exec May 6
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $2.6M
63,980 sh across 2 lots
Exec Apr 15
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $1.9M
60,000 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $1.8M
60,000 sh × $30.10
Exec Feb 20
Filed Feb 24 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $3.2M
100,087 sh across 2 lots
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $1.8M
60,000 sh across 2 lots
Exec Jan 23
Filed Jan 27 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $398K
18,924 sh × $21.05
Exec May 5 2025
Filed May 5 2025 · 5:30 PM ET